<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01458873</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-11-8716-IK-CTIL</org_study_id>
    <nct_id>NCT01458873</nct_id>
  </id_info>
  <brief_title>Intravenous Sodium Bicarbonate Verifies Intravenous Position of Catheters in Spontaneously Breathing Adult Volunteers</brief_title>
  <official_title>Intravenous Sodium Bicarbonate Verifies Intravenous Position of Catheters in Spontaneously Breathing Adult Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vascular access in patients carries a significant risk of accidental extravasation of
      intravenous (IV) fluids and medications with the potential for tissue injury. This
      prospective controlled study assessed the diagnostic utility of using intravenous diluted
      sodium bicarbonate to confirm placement of IV catheters in volunteers . Diluted sodium
      bicarbonate or 0.9% normal saline, will be injected in a randomized order while end-tidal
      carbon dioxide in the exhaled air will be monitored. The investigators hypothesize that the
      injected bicarbonate will dissolve into carbon dioxide and water and cause a transient
      increase in the measured exhaled CO2.

      The effect is unique to bicarbonate and will not appear once normal saline is injected. the
      safety of the administration of bicarbonate on the metabolic profile of the volunteers will
      be assessed by measurement of venous blood pH and electrolytes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vascular access in patients carries a significant risk of accidental extravasation of
      intravenous (IV) fluids and medications with the potential for tissue injury. This
      prospective controlled study assessed the diagnostic utility of using intravenous diluted
      sodium bicarbonate to confirm placement of IV catheters in volunteers . Diluted sodium
      bicarbonate or 0.9% normal saline, will be injected in a randomized order while end-tidal
      carbon dioxide in the exhaled air will be monitored. The investigators hypothesize that the
      injected bicarbonate will dissolve into carbon dioxide and water and cause a transient
      increase in the measured exhaled CO2. Arbitrary increase of more than 10%in end-tidal carbon
      dioxide is considered as a positive response.

      The effect is unique to bicarbonate and will not appear once normal saline is injected. the
      safety of the administration of bicarbonate on the metabolic profile of the volunteers will
      be assessed by measurement of venous blood pH and electrolytes.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2011</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>transient increase in end tidal carbon dioxide</measure>
    <time_frame>4-12 seconds</time_frame>
    <description>Once sodium bicarbonate is injected the measured end-tidal carbon dioxide will transiently increase by at least 10% of baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in venous blood pH</measure>
    <time_frame>10-20 minutes</time_frame>
    <description>Blood pH and will be measured prior and ten minutes after the injections</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective adverse symptoms associated with injection of sodium bicarbonate</measure>
    <time_frame>1 minute</time_frame>
    <description>The subjective symptoms as well as hemodynamic changes associated with the injection of sodium bicarbonate will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in venous blood sodium</measure>
    <time_frame>10- 20 minutes</time_frame>
    <description>blood sodium level will be measured before and 10-20 minutes after the end of the injections.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in venous blood bicarbonate level</measure>
    <time_frame>10-20 minutes</time_frame>
    <description>blood level of bicarbonate will be measured before and 10-20 minutes after the injection.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in venous blood potasium level</measure>
    <time_frame>10-20 minutes</time_frame>
    <description>venous blood potasium level will be measured before and 10-20 minutes after injection</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Infiltration</condition>
  <condition>Extravasation</condition>
  <arm_group>
    <arm_group_label>sodium bicarbonate 4.2%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>sodium bicarbonate 4.2% 50 m&quot;l</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sodium bicarbonate 2.1%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>sodium bicarbonate 2.1% 1 50 m&quot;l</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normal saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>50 m&quot;l normal saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sodium bicarbonate 4.2%</intervention_name>
    <description>diluted sodium bicarbonate 50 ml</description>
    <arm_group_label>sodium bicarbonate 4.2%</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>diluted sodium bicarbonate 2.1%</intervention_name>
    <description>50ml</description>
    <arm_group_label>sodium bicarbonate 2.1%</arm_group_label>
    <other_name>sodium bicarbonate 2.1%</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>normal saline</intervention_name>
    <description>50ml</description>
    <arm_group_label>normal saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I,II

          -  no cardiovascular or respiratory disease

        Exclusion Criteria:

          -  ASA &gt; II

          -  Cardiovascular disease

          -  Respiratory disease

          -  renal failure

          -  metabolic alkalosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>ILAN KEIDAN, MD</last_name>
    <phone>972-3-5302754</phone>
    <email>ilan.keidan@sheba.health.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Tel Hashomer</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ilan keidan, MD</last_name>
      <phone>972-3-530-2754</phone>
      <email>ilan.keidan@sheba.health.gov.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Keidan I, Ben-Menachem E, Barzilai A, Nur I, Berkenstadt H. Intravenous sodium bicarbonate verifies intravenous position of catheters in ventilated patients. Anesth Analg. 2011 Aug;113(2):279-81. doi: 10.1213/ANE.0b013e3182222ed0. Epub 2011 Jun 3.</citation>
    <PMID>21642603</PMID>
  </reference>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 9, 2011</study_first_submitted>
  <study_first_submitted_qc>October 21, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 25, 2011</study_first_posted>
  <last_update_submitted>October 30, 2011</last_update_submitted>
  <last_update_submitted_qc>October 30, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 1, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sheba Medical Center</investigator_affiliation>
    <investigator_full_name>Dr. Ilan Keidan</investigator_full_name>
    <investigator_title>Director, Pediatric Anesthesia, Sheba Medical center</investigator_title>
  </responsible_party>
  <keyword>infiltration</keyword>
  <keyword>extravasation</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

